AXSOME THERAPEUTICS INC (AXSM) Forecast, Price Target & Analyst Ratings

NASDAQ:AXSM • US05464T1043

167.18 USD
+2.69 (+1.64%)
Last: Mar 10, 2026, 01:54 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AXSOME THERAPEUTICS INC (AXSM).

Forecast Snapshot

Consensus Price Target

Price Target
$223.66
+ 33.79% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release DateMay 4, 2026
PeriodQ1 / 2026
EPS Estimate-$0.84
Revenue Estimate197.89M
 → Full earnings forecast details

ChartMill Buy Consensus

Rating
85.38%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$223.66
Upside
+ 33.79%
From current price of $167.18 to mean target of $223.66, Based on 26 analyst forecasts
Low
$154.53
Median
$223.89
High
$273.00

Price Target Revisions

1 Month
2.92%
3 Months
22.68%

Price Target Summary

26 Wall Street analysts provided a forecast for the next 12 months for AXSM. The average price target is 223.66 USD. This implies a price increase of 33.79% is expected in the next year compared to the current price of 167.18.
The average price target has been revised upward by 22.68% in the past 3 months.
 → Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

AXSM Current Analyst RatingAXSM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10

Analyst Ratings History

AXSM Historical Analyst RatingsAXSM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20 25

Analyst Ratings Consensus

ChartMill Buy Consensus
85.38%
AXSM was analyzed by 26 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about AXSM.
In the previous month the buy percentage consensus was at a similar level.
AXSM was analyzed by 26 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-24GuggenheimMaintains Buy -> Buy
2026-02-24Wolfe ResearchInitiate Outperform
2026-02-24UBSMaintains Buy -> Buy
2026-02-24RBC CapitalMaintains Outperform -> Outperform
2026-02-24Wells FargoMaintains Overweight -> Overweight
2026-02-23NeedhamReiterate Buy -> Buy
2026-02-03JefferiesMaintains Buy -> Buy
2026-01-28Leerink PartnersMaintains Outperform -> Outperform
2026-01-21RBC CapitalMaintains Outperform -> Outperform
2026-01-20HC Wainwright & Co.Maintains Buy -> Buy
2026-01-16Piper SandlerMaintains Overweight -> Overweight
2026-01-13Wells FargoMaintains Overweight -> Overweight
2026-01-08Morgan StanleyDowngrade Overweight -> Equal-Weight
2026-01-06UBSMaintains Buy -> Buy
2026-01-05HC Wainwright & Co.Maintains Buy -> Buy
2025-12-31NeedhamMaintains Buy -> Buy
2025-11-06MizuhoMaintains Outperform -> Outperform
2025-11-04GuggenheimMaintains Buy -> Buy
2025-11-04NeedhamReiterate Buy -> Buy
2025-11-04RBC CapitalMaintains Outperform -> Outperform
2025-11-04Wells FargoMaintains Overweight -> Overweight
2025-11-04Morgan StanleyMaintains Overweight -> Overweight
2025-11-04HC Wainwright & Co.Maintains Buy -> Buy
2025-10-20Morgan StanleyMaintains Overweight -> Overweight
2025-10-01B. Riley SecuritiesInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release DateMay 4, 2026
PeriodQ1 / 2026
EPS Estimate-$0.84
Revenue Estimate197.89M
Revenue Q2Q62.92%
EPS Q2Q30.96%
Number of Analysts21

Next Earnings Revisions

Revenue (1 Month)
1.54%
Revenue (3 Months)
1.50%
EPS (1 Month)
-31.42%
EPS (3 Months)
-28.44%

Next Earnings Summary

AXSM is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.84 USD and the consensus revenue estimate is 197.89M USD.
The next earnings revenue estimate has been revised upward by 1.5% in the past 3 months.
 → Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
AXSM revenue by date.AXSM revenue by date.
270.6M
440.77%		385.693M
42.53%		638.496M
65.55%		1.011B
58.34%		1.56B
54.30%		2.198B
40.90%		2.811B
27.89%		3.342B
18.89%		3.584B
7.24%		3.72B
3.79%		4.158B
11.77%
EBITDA
YoY % growth
AXSM ebitda by date.AXSM ebitda by date.
-224.991M
-28.64%		-272.604M
-21.16%		-159.998M
41.31%		11.36M
107.10%		382.08M
3,263.38%		761.21M
99.23%		1.402B
84.18%		1.804B
28.67%		1.354B
-24.94%		1.551B
14.55%		1.732B
11.67%
EBIT
YoY % growth
AXSM ebit by date.AXSM ebit by date.
-231.825M
-29.29%		-280.562M
-21.02%		-169.062M
39.74%		65.91M
138.99%		467.03M
608.59%		852.04M
82.44%		1.422B
66.89%		1.808B
27.14%		1.905B
5.37%		1.959B
2.83%		2.153B
9.90%
Operating Margin
AXSM operating margin by date.AXSM operating margin by date.
-85.67%-72.74%-26.48%6.52%29.94%38.76%50.59%54.10%53.15%52.66%51.78%
EPS
YoY % growth
AXSM eps by date.AXSM eps by date.
-5.20
-13.79%		-5.99
-15.19%		-3.69
38.40%		-0.69
81.24%		6.65
1,060.33%		14.56
119.05%		20.92
43.65%		27.34
30.72%		23.17
-15.24%		24.57
6.03%		28.53
16.11%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.84
30.96%		-0.49
49.80%		0.39
141.29%		1.14
303.07%		1.60
290.14%		2.36
583.89%		3.10
698.95%		3.94
246.23%
Revenue
Q2Q % growth		197.89M
62.92%		230.22M
53.44%		273M
59.66%		320.63M
63.59%		367.7M
85.81%		428.93M
86.31%		486.54M
78.22%		549.6M
71.41%
EBITDA
Q2Q % growth		-44.528M
22.08%		-29.901M
7.53%		20.502M
152.14%		27.407M
253.17%		92.198M
307.06%		116.74M
490.42%		139.4M
579.93%		176.98M
545.75%
EBIT
Q2Q % growth		-41.537M
29.93%		-25.74M
29.89%		29.831M
164.70%		74.975M
378.13%		92.198M
321.96%		116.74M
553.53%		139.4M
367.30%		176.98M
136.05%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

AXSM Yearly Revenue VS EstimatesAXSM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B 4B
AXSM Yearly EPS VS EstimatesAXSM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 20

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
81.16%
EPS Next 5 Year
56.57%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
50.26%
Revenue Next 5 Year
38.84%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
91.11%
EBIT Next 5 Year
69.04%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

AXSOME THERAPEUTICS INC / AXSM Forecast FAQ

Can you provide the average price target for AXSOME THERAPEUTICS INC stock?

26 analysts have analysed AXSM and the average price target is 223.66 USD. This implies a price increase of 33.79% is expected in the next year compared to the current price of 167.18.


Can you provide the upcoming earnings date for AXSOME THERAPEUTICS INC?

AXSOME THERAPEUTICS INC (AXSM) will report earnings on 2026-05-04.


What are the consensus estimates for AXSOME THERAPEUTICS INC (AXSM) next earnings?

The consensus EPS estimate for the next earnings of AXSOME THERAPEUTICS INC (AXSM) is -0.84 USD and the consensus revenue estimate is 197.89M USD.


What is the expected long term growth rate for AXSM stock?

The expected long term growth rate for AXSOME THERAPEUTICS INC (AXSM) is 50.26%.